$1.43
-0.19-11.73%
Last update: Nov 12, 5:51 PM
Neuronetics Inc
STIMNASDAQ
Neuronetics fell 33.8% from $2.16 to $1.43, behind the S&P 500's +10.8%. Its worst day was Nov 11 (−19.4%), and its low came May 18 at $1.18.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Neuronetics shares rose 19.9%, while the S&P 500 rose 0.6%.
+19.9% · S&P 500 +0.6%
Neuronetics shares jumped 41% in after-hours trading following strong preliminary fourth-quarter 2025 revenue results.
Story events cover the past 12 months · Times ET
+23.3% · S&P 500 0.0%
EPS of $-0.10 beat the $-0.11 estimate on $41.8M revenue (est. $40.8M); FY revenue guidance of $160.0M–$166.0M against the $164.4M consensus.
−9.9% · S&P 500 +0.3%
EPS of $-0.16 beat the $-0.17 estimate on $34.5M revenue (est. $34.2M); FY revenue guidance of $160.0M–$166.0M against the $162.3M consensus.
+7.4% · S&P 500 +0.8%
Neuronetics closed at its lowest level of the year, 45.4% below where the year started.
−7.8% · S&P 500 −0.1%
Neuronetics shares rose 26.2%, while the S&P 500 rose 0.6%.
+26.2% · S&P 500 +0.6%
Neuronetics shares rose 24.7%, while the S&P 500 fell 0.2%.
+24.7% · S&P 500 −0.2%
EPS of $-0.05 beat the $-0.12 estimate on $41.6M revenue (est. $40.2M); FY revenue guidance of $160.0M–$164.0M against the $161.0M consensus.
+47.0%, the year's best day, on 29M shares, the year's heaviest volume · S&P 500 −0.3%
EPS of $-0.02 beat the $-0.10 estimate on $42.0M revenue (est. $40.5M); FY revenue guidance of $160.0M–$164.0M against the $162.2M consensus.
+19.7% · S&P 500 +1.7%
Where it ended: a close of $1.43 on Nov 12, 2026.
Nothing in the past 12 months.
All STIM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for STIM and SPY from Benzinga historical bars. Not investment advice.
